Precision Biosensor Statistics

Total Valuation

Precision Biosensor has a market cap or net worth of KRW 32.87 billion. The enterprise value is 44.95 billion.

Market Cap	32.87B
Enterprise Value	44.95B

Important Dates

The next estimated earnings date is Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Precision Biosensor has 11.61 million shares outstanding. The number of shares has increased by 0.17% in one year.

Current Share Class	n/a
Shares Outstanding	11.61M
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.43%
Owned by Institutions (%)	2.22%
Float	7.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.80
PB Ratio	1.20
P/TBV Ratio	1.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.61
EV / Sales	2.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.33

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.63.

Current Ratio	2.89
Quick Ratio	1.23
Debt / Equity	0.63
Debt / EBITDA	n/a
Debt / FCF	-8.20
Interest Coverage	-3.41

Financial Efficiency

Return on equity (ROE) is -27.12% and return on invested capital (ROIC) is -9.34%.

Return on Equity (ROE)	-27.12%
Return on Assets (ROA)	-7.75%
Return on Capital (ROIC)	-9.34%
Revenue Per Employee	178.58M
Profits Per Employee	-78.52M
Employee Count	102
Asset Turnover	0.32
Inventory Turnover	1.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.27%
50-Day Moving Average	3,144.70
200-Day Moving Average	4,028.43
Relative Strength Index (RSI)	40.96
Average Volume (20 Days)	13,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Precision Biosensor had revenue of KRW 18.22 billion and -8.01 billion in losses. Loss per share was -689.87.

Revenue	18.22B
Gross Profit	5.27B
Operating Income	-7.10B
Pretax Income	-8.71B
Net Income	-8.01B
EBITDA	-3.64B
EBIT	-7.10B
Loss Per Share	-689.87

Full Income Statement

Balance Sheet

The company has 5.21 billion in cash and 17.29 billion in debt, giving a net cash position of -12.08 billion or -1,039.74 per share.

Cash & Cash Equivalents	5.21B
Total Debt	17.29B
Net Cash	-12.08B
Net Cash Per Share	-1,039.74
Equity (Book Value)	27.29B
Book Value Per Share	2,349.88
Working Capital	10.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.66 billion and capital expenditures -451.30 million, giving a free cash flow of -2.11 billion.

Operating Cash Flow	-1.66B
Capital Expenditures	-451.30M
Free Cash Flow	-2.11B
FCF Per Share	-181.45

Full Cash Flow Statement

Margins

Gross margin is 28.96%, with operating and profit margins of -39.00% and -43.97%.

Gross Margin	28.96%
Operating Margin	-39.00%
Pretax Margin	-47.81%
Profit Margin	-43.97%
EBITDA Margin	-20.00%
EBIT Margin	-39.00%
FCF Margin	n/a

Dividends & Yields

Precision Biosensor does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.17%
Shareholder Yield	-0.17%
Earnings Yield	-24.38%
FCF Yield	-6.41%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Precision Biosensor has an Altman Z-Score of 0.39. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.39
Piotroski F-Score	n/a